Search

Your search keyword '"Dwivedi, Raghav"' showing total 414 results
Start Over Author "Dwivedi, Raghav"
414 results on '"Dwivedi, Raghav"'

151. Medullary Thyroid Cancer

Author

Chin-Lenn, Laura, Pasieka, Janice L., Kazi, Rehan, Series editor, Dwivedi, Raghav C., Series editor, Pathak, K. Alok, editor, Nason, Richard W., editor, and Pasieka, Janice L., editor

Published
2015
Full Text
View/download PDF

156. Targeted Therapies in Thyroid Cancer

Author

Abadin, Shabirhusain S., Busaidy, Naifa L., Perrier, Nancy D., Kazi, Rehan, Series editor, Dwivedi, Raghav C., Series editor, Pathak, K. Alok, editor, Nason, Richard W., editor, and Pasieka, Janice L., editor

Published
2015
Full Text
View/download PDF

169. Endoscopic Skull Base Surgery

Author

Gil, Ziv, Abergel, Avraham, Margalit, Nevo, Kazi, Rehan, Series editor, Dwivedi, Raghav C., Series editor, Gil, Ziv, editor, and Fliss, Dan M., editor

Published
2012
Full Text
View/download PDF

184. Mandible-Preserving Alternatives

Author

Pathak, K. Alok, Kazi, Rehan, Nason, Richard W., Kazi, Rehan, Series editor, Dwivedi, Raghav C., Series editor, Pathak, K. Alok, editor, and Nason, Richard W., editor

Published
2012
Full Text
View/download PDF

192. Staging of Differentiated Thyroid Cancer

Author

Wysocki, Wojciech M., Komorowski, Andrzej L., Greene, Frederick L., Kazi, Rehan, Series editor, Dwivedi, Raghav C., Series editor, Greene, Frederick L., editor, and Komorowski, Andrzej L., editor

Published
2012
Full Text
View/download PDF

194. Imaging in Thyroid Cancer

Author

Gwyther, Stephen J., Kazi, Rehan, Series editor, Dwivedi, Raghav C., Series editor, Greene, Frederick L., editor, and Komorowski, Andrzej L., editor

Published
2012
Full Text
View/download PDF

199. A case-control study of Drug-Induced Sleep Endoscopy (DISE) in pediatric population: A proposal for indications.

Author

Collu, Maria Antonietta, Esteller, Eduard, Lipari, Fiorella, Haspert, Raul, Mulas, Demetrio, Diaz, Miguel Angel, and Dwivedi, Raghav C.

Subjects
*SLEEP apnea syndrome treatment, *SLEEP apnea syndromes, *DRUG side effects, *JUVENILE diseases, *POLYSOMNOGRAPHY, *CASE-control method, *DIAGNOSIS
Abstract

Objective To evaluate whether and when Drug-Induced Sleep Endoscopy (DISE) changes diagnosis and treatment plan in pediatric Obstructive Sleep Apnoea Syndrome (OSAS) with the aim to identify specific subgroups of patients for whom DISE should be especially considered. Methods A case-control study of DISE in 150 children with OSAS. Pre-operative OSA were assessed through detailed history, Chervin questionnaire, physical examination and overnight polysomnography. The group of study was divided into three subgroups according to clinical and polysomnographyc criteria: conventional OSAS, disproportional OSAS and persistent OSAS. Endoscopic evaluation of the upper airway during DISE was scored using Chan classification. Surgical treatment was tailored individually upon the basis of sleep endoscopy findings: performance of any surgery other than tonsillectomy and adenoidectomy (T&A) was considered as a change of the treatment plan. Cases and controls were compared considering presence and absence of DISE-directed extra surgery, respectively. Results 150 patients with mean age (SD) 56.09 (23.94) months and mean apnoea-hypopnea index (AHI) of 5.79 (6.52) underwent DISE. The conventional subgroup represented the 58.67% of the sample (n = 88), while the disproportional one counted for the 26.67% (n = 40), and the persistent one for 14.66% (n = 22) of the population. Sleep endoscopy changed the surgical plan in 4.5% of conventional OSAS, 17.5% of disproportional OSAS and 72.7% of persistent OSAS (p < 0.005). Overall, a change of the treatment plan operated by DISE was associated with a non-conventional OSAS status (OR = 6; 95% CI = 1.6–26.4). Conclusions DISE is a safe procedure in children suffering from OSAS, and, despite being unnecessary in conventional cases of OSA, DISE should be considered not only in syndromic children, as previously demonstrated, but also in the general non-syndromic pediatric population, in the case of non-conventional OSA patients, and in children with persistent OSAS. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

200. Kaposiform haemangioendothelioma of the head and neck.

Author

Wong, Billy L.K., Lee, Vivian N.Y., Tikka, Theofano, Kim, Dae, and Dwivedi, Raghav C.

Subjects
*BLOOD-vessel tumors, *HEAD & neck cancer, *VASCULAR endothelial cells, *CANCER chemotherapy, *CANCER relapse
Abstract

Background Kaposiform haemangioendothelioma (KHE) is a tumor of intermediate malignant potential derived from vascular endothelial cells. Due to rarity of head neck KHE (HN-KHE) this comprehensive review aims to compile, analyze and present details to develop a consensus and augment available literature on HN-KHE. Materials and methods A comprehensive literature search was performed on PUBMED/MEDLINE, EMBASE, CINAHL and Science Citation Index for HN-KHE using MeSH words. Statistical analysis was performed using a variety of tests. Results Common sites of involvement were neck 41.5%, face and scalp 32.0% and tympanomastoid region in 13.2% patients. Kasabach-Merritt phenomenon was seen in 58.5% patients. Surgical excision was performed in 37.7% patients while 39.6% patients underwent medical management/chemotherapy (CT). Significantly better disease free survival (DFS) was seen in patients undergoing surgical excision vs. CT (p = 0.001), without recurrence vs. with recurrence (p = 0.001) and those presenting within 0–1 year of life vs. 1–5 years (p = 0.021). Conclusion Recurrence and metastasis were seen in 35.8% and 20.0% patients respectively. Complete surgical excision with clear margins remains the treatment of choice. [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results